Xuanfeng Ding

Title: Innovations in Particle Therapy by Inventor Xuanfeng Ding

Introduction

Xuanfeng Ding is a notable inventor based in Bloomfield Hills, MI, whose contributions to the field of particle therapy have led to significant advancements in the optimization of particle beam delivery. With a total of two patents to his name, Ding's work is crucial in the realm of medical technology.

Latest Patents

Ding's latest patents center around enhancing particle arc therapy. The first patent details a method for optimizing the delivery of a particle beam to a target. This innovation involves delivering a substantially continuous particle beam at multiple control points, allowing for iterative adjustments in delivery time. The method also encompasses processing steps to pre-define energy layers based on the control points and sampling frequency, as well as sorting these energy layers. The second patent focuses on the actual delivery of the particle beam at a target using similar techniques, emphasizing continuous delivery and control point management.

Career Highlights

Xuanfeng Ding is currently affiliated with William Beaumont Hospital, where he applies his expertise in particle therapy. His role encompasses not only the practical application of his inventions but also a commitment to advancing medical treatment modalities.

Collaborations

Throughout his career, Ding has collaborated with notable coworkers, including Xiaoqiang Li and Di Yan. Together, they contribute to a dynamic environment of innovation, working towards the common goal of improving patient care through advanced technologies.

Conclusion

Xuanfeng Ding stands out as a pioneering inventor in the field of particle therapy. His patents reflect a deep understanding of technology and its application in medicine, positioning him as a vital contributor to the evolving landscape of healthcare technology. As the field continues to advance, Ding's innovations will undoubtedly play a significant role in shaping future therapies and treatment options.